Liver fibrosis accompanies the progression of chronic liver diseases independent of
etiologies, such as hepatitis viral infection, alcohol consumption, and metabolic-associated …

Non-alcoholic fatty liver disease (NAFLD) exhibits increased lipid enrichment in
hepatocytes. The spectrum of this disease includes stages such as nonalcoholic simple fatty …

Chronic liver diseases usually developed through stepwise pathological transitions under
the persistent risk factors. The molecular changes during liver transitions are pivotal to …

Non-alcoholic fatty liver disease (NAFLD), characterized by the excessive accumulation of
fat within the cytoplasm of hepatocytes (exceeding 5% of liver weight) in individuals without …

Multi-cytokine-producing Th9 cells secrete IL-9 and type 2 cytokines and mediate mouse
and human allergic inflammation. However, the cytokines that promote a multi-cytokine …

In 2020, a revised definition of fatty liver disease associated with metabolic dysfunction
(MAFLD) was proposed to replace non-alcoholic fatty liver (NAFLD). Liver steatosis and at …

Circulating T cells, which migrate from the periphery to sites of tissue inflammation, play a
crucial role in the development of various chronic inflammatory conditions. Recent research …